Candriam Equities L Oncology Impact C/ LU1864484214 /
| NAV1/23/2025 | Chg.+2.5400 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 238.7100EUR | +1.08% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | - | - | - | - | -2.07 | 6.28 | 2.52 | 0.74 | -2.26 | 2.63 | 9.16 | 3.09 | - |
| 2020 | -0.26 | -4.57 | -3.04 | 12.24 | 6.81 | 0.37 | -0.88 | 0.93 | 5.50 | -1.62 | 2.97 | 1.47 | +20.47% |
| 2021 | 1.20 | -4.18 | 3.11 | -0.16 | -1.08 | 6.25 | -1.03 | 5.97 | -2.06 | 3.45 | -3.82 | 2.85 | +10.28% |
| 2022 | -9.27 | -2.01 | 5.56 | -0.78 | -2.91 | 2.43 | 6.93 | -1.86 | -2.27 | 6.01 | 1.74 | -6.92 | -4.65% |
| 2023 | 0.31 | -1.64 | -1.12 | 1.12 | 0.82 | -2.28 | -0.25 | -0.55 | -2.93 | -6.28 | 5.72 | 4.36 | -3.22% |
| 2024 | 3.00 | 4.46 | 1.62 | -2.49 | 0.85 | 2.41 | 4.65 | 1.75 | -3.94 | -3.06 | 0.41 | -5.03 | - |
| 2025 | 2.81 | - | - | - | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 13.38% | 13.77% | 12.28% | 14.06% | 17.11% |
| Sharpe ratio | 3.93 | -1.02 | 0.12 | 0.05 | 0.14 |
| Best month | +2.81% | +4.65% | +4.65% | +6.93% | +12.24% |
| Worst month | -5.03% | -5.03% | -5.03% | -9.27% | -9.27% |
| Maximum loss | -2.49% | -11.89% | -11.89% | -19.33% | -25.60% |
| Outperformance | - | - | - | - | - |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,252.8501 | +1.26% | +5.64% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,409.3501 | +1.39% | +6.04% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,150.4700 | +3.05% | +13.42% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,495.7000 | -0.20% | +3.74% | |
| Candriam Equities L Oncology Imp... | paying dividend | 18,769.0000 | -3.56% | -3.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,937.8101 | -2.03% | -3.89% | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,777.5100 | +3.37% | +19.10% | |
| Candriam Equities L Oncology Imp... | reinvestment | 191.0000 | -1.84% | -5.77% | |
| Candriam Equities L Oncology Imp... | reinvestment | 238.7100 | +4.18% | +10.64% | |
| Candriam Equities L Oncology Imp... | paying dividend | 217.9400 | -1.12% | +0.86% | |
| Candriam Equities L Oncology Imp... | paying dividend | 177.4800 | -0.29% | +3.44% | |
| Candriam Equities L Oncology Imp... | reinvestment | 152.0400 | +2.95% | +13.04% | |
| Candriam Equities L Oncology Imp... | reinvestment | 251.6700 | +4.17% | +12.26% | |
| Candriam Equities L Oncology Imp... | reinvestment | 188.4100 | -3.33% | -7.66% | |
| Candriam Equities L Oncology Imp... | reinvestment | 266.1300 | -0.29% | +3.43% | |
| Candriam Equities L Oncology Imp... | reinvestment | 177.9800 | -2.06% | -4.10% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,677.2000 | -0.20% | +3.74% | |
| Candriam Equities L Oncology Imp... | reinvestment | 153.0500 | +0.33% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 253.2100 | -1.12% | +0.86% |
Performance
| YTD | +2.81% | ||
|---|---|---|---|
| 6 Months | -5.88% | ||
| 1 Year | +4.18% | ||
| 3 Years | +10.64% | ||
| 5 Years | +27.88% | ||
| Since start | +59.14% | ||
| Year | |||
| 2023 | -3.22% | ||
| 2022 | -4.65% | ||
| 2021 | +10.28% | ||
| 2020 | +20.47% | ||